Navigation Links
Cell Therapeutics, Inc. (CTI) Cuts Net Operating Expenses 35% and Expands Commercial Team to Support Zevalin(R) Sales and Applications Seeking Two Product Approvals in 2009
Date:1/30/2008

tential for these severe cardiotoxicities, as well as to potentially increase activity and simplify administration compared to the currently marketed anthracyclines. The main adverse events associated with pixantrone in clinical trials to date include myelosuppression and alopecia.

About Brostallicin

Brostallicin, which was initially developed by Nerviano Medical Sciences, the largest pharmaceutical research and development facility in Italy, is a synthetic second-generation DNA minor groove binder with potent cancer killing activity in experimental tumors models. More than 200 patients have been treated with brostallicin in single-agent and combination studies, and it is now in a first-line phase II study that is currently being conducted by the European Organization for Research and Treatment of Cancer (EORTC).

About Cell Therapeutics, Inc.

Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit http://www.cticseattle.com.

This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results. Specifically, the risks and uncertainties that could affect the marketing and development of ZEVALIN, or the development of XYOTAX, pixantrone and brostallicin include risks associated with preclinical and clinical developments in the biopharmaceutical industry in general and with ZEVALIN, XYOTAX, pixantrone and brostallicin in particular including, without limitation, the potential failure of these product candidates to prove safe and effective for treatment of non-small cell lung cancer, ovarian cancer, non-Hodgkin's lymphoma, and sarcoma, determinations by regulatory, patent and administrative governmental authoritie
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Reckitt Benckiser Completes Acquisition of Adams Respiratory Therapeutics, Inc.
2. Cell Therapeutics, Inc. (CTI) Completes Acquisition of Lymphoma Drug Zevalin(R) From Biogen Idec for Sales and Marketing in the United States
3. Cell Therapeutics, Inc. Announces $6.5 Million Offering
4. Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008
5. Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.s Drug Pipeline
6. InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer
7. Cell Therapeutics, Inc. (CTI) Appoints Jim Fong as Vice President, Commercial Operations
8. Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and Third Quarter 2007 Financial Results
9. Cell Therapeutics, Inc. (CTI) to Report Third Quarter Financial Results on November 8
10. Cell Therapeutics, Inc. (CTI) CIBC and Rodman & Renshaw Healthcare Conference Presentations to be Webcast
11. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... Port Richey, FL (PRWEB) May 29, 2015 ... that nearly one in 10 full-time workers has a substance ... and 2012 from more than 111,500 adults with full-time jobs, ... alcohol disorder in the previous year. (1) The National Council ... employers $81 billion per year, and an estimated 70% of ...
(Date:5/29/2015)... 2015 Johnson & Johnson and ... Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ) settlement with a ... his use of the antipsychotic medication. According to ... the third bellwether trial to involve male breast ... in Pennsylvania’s Philadelphia Court of Common Pleas, where ...
(Date:5/29/2015)... Inspire Nexus, a new social network ... the question many life coaches have asked, "How do ... hours necessary to become a credentialed Coach?" , Many ... not for long. Inspire Nexus, a social network for ... Coaches who have experience coaching a certain number of ...
(Date:5/29/2015)... 2015 OncLive proudly announces the 2015 ... pioneers recognized by a panel of eminent oncologists for ... treatment. Honorees will be introduced and celebrated TONIGHT at ... held 8:30-11:00 p.m. CDT at The Chicago Illuminating Company, ... being recognized for groundbreaking accomplishments, in fields including translational ...
(Date:5/29/2015)... May 29, 2015 The Global ... in-depth study on the current state of the ... provides key statistics on the state of the ... and direction for companies and individuals interested in ... of the industry including definitions, classifications, applications and ...
Breaking Medicine News(10 mins):Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 2Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 3Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 4Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 3Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 3Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 4Health News:Allopurinol Industry (Global, China) 2015 Research Analysis and 2020 Forecasts 2
... of Ages ... Fundraiser, RESEDA, Calif., Oct. 16 ... the United States to either,join or give a dollar when it hosts its ... official census records there,are 663,233 people in the country with that last name. ...
... Operations, Security and, Maintenance Services ... ARLINGTON, Va., Oct. 16 Vangent, Inc., ... business process outsourcing,solutions, today announced it has ... and Decision Support (EIDS) Infrastructure,Operations, Security and ...
... of Florida scientists have discovered how HIV evolves over the ... that heralds the onset of full-blown AIDS. The findings could ... virus earlier in the disease process, before it takes a ... understanding how the virus mutates from the beginning of the ...
... say , TUESDAY, Oct. 16 (HealthDay News) -- When ... epilepsy drug lamotrigine is effective in controlling partial seizures, ... 13 and older, were recruited from the United States ... or two medications, but these did not fully control ...
... Local Public Schools for Career Development, VIRGINIA ... AGP ) will host more than 50 high ... in Virginia Beach as part of the,Company,s participation ... by the American Association of People with,Disabilities (AAPD) ...
... Do Customers Come From?, Enables Public To Give And ... ... Where Do Customers Come,From?, the new Internet marketing book by successful New ... publishing,world for its timely content and the author,s generous charitable campaign,Billy Gives ...
Cached Medicine News:Health News:FORGET THE JONESES, This is All About Keeping up With the Walkers as the Los Angeles Jewish Home Sends Out an Invite to Everyone Named 'Walker' in the United States 2Health News:Vangent, Inc. Awarded Contract to Support Military Health System's Executive Information and Decision Support Program 2Health News:UF researchers track genetic journey of HIV from birth to death 2Health News:UF researchers track genetic journey of HIV from birth to death 3Health News:Lamotrigine May Reduce Epilepsy Seizures 2Health News:AMERIGROUP to Participate in National Disability Mentoring Day 2Health News:AMERIGROUP to Participate in National Disability Mentoring Day 3Health News:New Jersey Entrepreneur Turns a Page for Four National Charities 2
(Date:5/29/2015)... 28, 2015 Research and Markets ( http://www.researchandmarkets.com/research/64lx2w/north_america_mri ... America MRI Market - Growth, Trends And Forecasts (2014 ... The North American MRI systems market is estimated to ... $1.58 billion by 2020 with a CAGR of 2.9% ... types namely, the open system, closed system and the ...
(Date:5/29/2015)... DUBLIN , May 28, 2015 Research ... of the "North America Open System MRI Market ... report to their offering. The key players ... , Philips Healthcare, Siemens Healthcare and Toshiba Medical Systems ... tool which is replacing CT because of its higher ...
(Date:5/29/2015)... , May 29, 2015  The annual customer satisfaction ... ranks Praxis EMR as #1 across all specialties. Every ... Research LLC conducts a poll of EHR users and ... results.    Praxis EMR topped 348 ... 18 performance based criteria used by Black Book. In ...
Breaking Medicine Technology:North America MRI Market - Growth, Trends And Forecasts 2014-2019 with GE, Hitachi Medical, Philips Healthcare, Siemens Healthcare & Toshiba Medical Systems Dominating 2North America Open System MRI Market 2014-2019 with GE, Hitachi Medical, Philips Healthcare, Siemens Healthcare and Toshiba Medical Dominating 2Praxis EMR Ranks #1 for Physician Satisfaction in Black Book's 2015 Survey of Solo and Small Practices 2
... RDEA594 Data to Be Presented at the 2008 Annual European Congress of, Rheumatology ... Phase 1 Human Study of RDEA594 Planned in Second Half of ... ... Biosciences, Inc.,(Nasdaq: RDEA ) today announced the identification of its lead development,candidate ...
... filing anticipated in 1Q 2009 -, PRINCETON, ... ) has nominated PSI-7851 as a lead development ... (HCV). PSI-7851 is a proprietary,nucleotide analogue polymerase inhibitor ... Practice (GLP) animal toxicity studies required for,submission of ...
Cached Medicine Technology:Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 2Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 3Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 4Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 5Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C 2Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C 3
... aluminum cuffs that can be bent to ... joint alignment, unique slot/screw adjustment mechanism allows ... cuff position. Cuffs are configured to offer ... with contractures.,The hinge can be locked in ...
... Elbow Wrap replaces messy taping and bulky ... others experiencing epicondylitis. Preferred by doctors and ... fit. Two overlay straps allow you to ... lining holds the Elbow Wrap comfortably in ...
... The Bledsoe Original Arm Brace is ... elbow strains and ligament trauma. The Bledsoe ... limited R.O.M. or locked control of the ... Bledsoe Extender Arm Brace can be formed, ...
... lightweight brace allows it to fit easily into ... joint following severe sprains, tendonitis or after cast ... with the ankle and provide optimum medial-lateral support. ... rotational strains on the ankle, and they provide ...
Medicine Products: